Skip to main content
. 2004 Sep 10;8(6):R358–R366. doi: 10.1186/cc2925

Table 2.

Electrodiagnostic and histopathological findings in 15 patients with neuromuscular weakness syndromes

Patient Typea Electromyography Muscular biopsy Nerve biopsy

Concentric needle examinatioin Motor nerve conduction Sensory nerve conduction Atrophy Necrosis Myosin loss Axonal degeneration Demyelination

FP LP Recruitmentb

0 1 2 3 CV (m/s) CMAP (mV) CV (m/s) CMAP (µV)
1 N + + Peroneal 46/ulnar 68 1/0.1 I/II +
2 N + + Peroneal 0/median 0 0/0 Sural 0/radial 0 0/0 II + +
3 N + + + Peroneal 33 0.1 Peroneal 41 10 I + +
4 N + + Peroneal 26/median 37 1/1 Peroneal 35/median 38 2/1 I/II + +
5 N + + + Peroneal 41 3 Peroneal 33 4 I/II + + +
6 N + + + Peroneal 40 2 Peroneal 36/radial 48 7/48 I/II + + +
7 NM + + Peroneal 0 0 Peroneal 0 0 I/II + + +
8 NM + + Peroneal 0 0 Peroneal 0 0 I/II + + +
9 NM + + + Peroneal 38 0.1 Peroneal 35/radial 48 3/8 I/II + + +
10 M + + + + Peroneal 36/median 34 0.8/0.8 Peroneal 52/radial 56 7/16 II + + No No
11 M + Peroneal 42 1.6 Peroneal 58 12 II + No No
12 M + + Peroneal 35 1.2 Peroneal 43/radial 43 20/22 I/II + No No
13 M + Peroneal 39 0.8 Peroneal 42 24 II + No No
14 M + + + + Peroneal 43 1.6 Peroneal 44 12 II + + No No
15 M + + Peroneal 40 1.0 Peroneal 42 7 II + No No

aType of neurological lesion. bRecruitment (muscular contraction): 0, absent; 1, simple; 2, weak intermediate; 4, rich intermediate. Recruitment data not available for patients 4, 8 and 12. CMAP, compound muscle action potential; CV, conduction velocity; FP, fibrillation potentials; LP, slow potentials of denervation; M, myopathy; N, neuropathy; NM, neuromyopathy.